SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-18-000008
Filing Date
2018-02-15
Accepted
2018-02-15 17:28:32
Documents
33
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 10-KQ peakpharmaceuticals_10q.htm 10-Q 182979
2 CERTIFICATION ex_31-1.htm EX-31.1 9026
3 CERTIFICATION ex_31-2.htm EX-31.2 9031
4 CERTIFICATION ex_32-1.htm EX-32.1 4385
5 CERTIFICATION ex_32-2.htm EX-32.2 3886
  Complete submission text file 0001199835-18-000008.txt   859986

Data Files

Seq Description Document Type Size
6 pkph-20171231.xml EX-101.INS 86408
7 pkph-20171231.xsd EX-101.SCH 11707
8 pkph-20171231_cal.xml EX-101.CAL 13425
9 pkph-20171231_def.xml EX-101.DEF 26849
10 pkph-20171231_lab.xml EX-101.LAB 82595
11 pkph-20171231_pre.xml EX-101.PRE 63772
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

IRS No.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 18618794
SIC: 2834 Pharmaceutical Preparations